I suspect that whatever the reason for the “pause in trading” announcement it was pre-empted by an unexpected event. If I’m correct, we can forget about a partnership (they don’t come out of the blue). The company appears totally unprepared as was suggested by @Pharmagang.
So where does that leave us and more importantly the company?
An announcement by the FDA? Or, a surprise takeover offer? GG finally showing his hand?
Looks like the company has been caught on the hop and is deciding the best way forward.
All conjecture on my part but the longer this drags on the more likely it’s not something the company wants.
Ann: Pause in Trading, page-59
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.075(5.12%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $9.337M | 6.672M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 80200 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 28642 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |